Placeholder text here for now Placeholder text here for now Placeholder text here for now Placeholder text here for now Placeholder text here for now
Precision cancer risk prediction for tailored treatment and insurance coverage assessment.
Precision cancer risk prediction for tailored treatment and insurance coverage assessment.
This is also just placeholder text for now
Hereditary Cancer
Risk Assessment Module
Created by genetics experts, the RISE tool is a feasible and effective way to identify
patients for genetic testing in an interdisciplinary breast cancer clinic without a genetic counselor
RISE Risk Assessment Results
95%
completion
rate
5
minutes on average
to complete
~86%
of breast cancer patients met
testing criteria
1 National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer. J Clin Oncol. 2017
2 Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011
View the Research
Fill out the form to view more of our research studies on digital tools for genomic medicine.
View the Poster
Fill out the form to view
and download the poster.